ElevateBio is a private discovery tools (healthcare) company. It has raised $926 million across 2 recorded rounds; the latest was a $401 million Series D in May 2023.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$926.0M
Last round
Later Stage VC (Series D)
May 2023
Investors — not yet on record
No investors in ElevateBio are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ElevateBio with a free account
·Watch ElevateBio: the Monday email on marks, rounds and moves
